CONGRUENCE THERAPEUTICS
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.
CONGRUENCE THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical
Founded:
2021-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.congruencetx.com
Total Employee:
11+
Status:
Active
Total Funding:
63 M CAD
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Complement Therapeutics
Complement Therapeutics operates as a preclinical stage company.
CuraSen Therapeutics
CuraSen Therapeutics is a biopharmaceutical company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Delix Therapeutics
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
Empower Therapeutics
Empower Therapeutics operates as a digital therapeutics company.
Enrich Therapeutics
Enrich Therapeutics is a biotechnology startup.
Eyebiotech
Eyebiotech is a privately held ophthalmology biotechnology company.
EZlifeBio
EZlifeBio is an EFIRM electric field-induced release and detection technology company.
Francis Medical
Francis Medical is a Medical Technology Company.
Indapta Therapeutics
Indapta Therapeutics is a privately held biotechnology company.
Kira Biotech
Kira Biotech is an Immunology Company.
Kovina Therapeutics
Kovina Therapeutics operates as a pre-clinical biotechnology company.
Libra Therapeutics
Libra Therapeutics is a biotechnology company.
Light Science Technologies
Light Science Technologies operates as a light, science and technology company.
Mnemo Therapeutics
Mnemo Therapeutics specializes in biotechnology and life science.
MOMA Therapeutics
MOMA Therapeutics operates as a biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
Proteinea
Insect-based biotechnology
Red Queen Therapeutics
Red Queen Therapeutics is a Cambridge biotechnology company.
RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology company.
Signia Therapeutics
Signia Therapeutics is an innovative French start-up company.
Terray Therapeutics
Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.
Adventa Bioscience
Nutraceutical, Bioceutical, Biotechnology
Investors List
Investissement Quebec
Investissement Quebec investment in Series A - Congruence Therapeutics
OrbiMed
OrbiMed investment in Series A - Congruence Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Series A - Congruence Therapeutics
Amplitude Venture Capital
Amplitude Venture Capital investment in Series A - Congruence Therapeutics
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series A - Congruence Therapeutics
Lumira Ventures
Lumira Ventures investment in Series A - Congruence Therapeutics
Clarissa Desjardins
Clarissa Desjardins investment in Series A - Congruence Therapeutics
Official Site Inspections
http://www.congruencetx.com
- Host name: 22.198.139.34.bc.googleusercontent.com
- IP address: 34.139.198.22
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Congruence Therapeutics"
Who We Are - Congruence
ABOUT US We are Changing the Drug Discovery Paradigm Congruence Therapeutics is a drug discovery company harnessing the power of innovative fields such as protein dynamics, …See details»
Congruence Therapeutics - Crunchbase Company …
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.See details»
Contact Us - Congruence
Contact Us Need to reach us? Headquarters Location7171 Rue Frederick-Banting, 117Montreal, Quebec, H4S 1Z9,CanadaUS LocationCongruence Therapeutics USA Inc.1340 Environ way, Suite 306Chapel Hill, NC, 27517See details»
Congruence Therapeutics - adMare Bio
For more information, visit: www.congruencetx.com . Back to list. Back to news list. Newsletter Stay up to date on the latest adMare news. Subscribe. Français. Vancouver Innovation …See details»
Congruence Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Congruence Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 13 news, Disease Domain:Endocrinology and Metabolic Disease, Nervous System …See details»
Congruence Therapeutics Company Overview, Contact Details
Mar 6, 2023 CongruenceTX is developing lead program CGX Program 1. Through its Revenir platform, Congruence Therapeutics is developing its lead program CGX Program 1 as well as …See details»
Congruence Therapeutics - Company Profile - Tracxn
Dec 11, 2024 Congruence Therapeutics - Developer of therapeutics for the treatment of rare diseases. Raised a total funding of $65M over 2 rounds from 9 investors. Founded by Clarissa …See details»
Congruence Therapeutics - PitchBook
Congruence Therapeutics General Information Description. Developer of pharmacological stabilizer designed for the treatment of rare diseases. The company uses the interface of computational and experimental drug …See details»
Overview, News & Similar companies - ZoomInfo.com
Apr 23, 2024 View Congruence Therapeutics (www.congruencetx.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as …See details»
Congruence Therapeutics - VentureRadar
Website: https://congruencetx.com/ Develops advanced drug discovery techniques using protein dynamics, biophysics, machine learning, AI, and computational chemistry ...See details»
Careers - Congruence
Congruence Life At Congruence, we are building a world-class team of drug hunters to efficiently design small molecules for diseases with high unmet medical need. We are a growing …See details»
Congruence Therapeutics Inc. Announces US$50 million Series
Feb 8, 2022 For more information, please visit www.congruencetx.com. Company Contact Charles Grubsztajn Chief Operating Officer [email protected] Media Contact David Rosen …See details»
Ono Enters into Drug Discovery Collaboration Agreement with …
Dec 3, 2024 Congruence’s proprietary scalable platform, Revenirâ„¢, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric …See details»
Congruence Therapeutics (Canada) Funding: $64.6M - Medical …
Nov 26, 2024 Congruence Therapeutics is building a team of 'drug hunters' to go after rare disease...See details»
Congruence Therapeutics Strengthens Leadership Team
Nov 22, 2022 [email protected] Media Contact Amy Conrad Juniper Point [email protected] 858-366-3243 .See details»
Congruence Therapeutics Inc. Announces US$50 million Series A …
Feb 8, 2022 Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases …See details»
Chief Operating Officer at Congruence Therapeutics - ZoomInfo
Charles Grubsztajn contact details: Email address: c***@congruencetx.com Phone number: (***) ***-**** Who is Charles Grubsztajn? Charles Grubsztajn is the Chief Operating Officer at …See details»
Careers - new - Congruence
Congruence Life At Congruence, we are building a world-class team of drug hunters to efficiently design small molecules for diseases with high unmet medical need. We are a growing …See details»
News and Events - Congruence
Nov 3, 2024 News & Events Recent News Follow us on Social Events November 3-6, 2024, in San Antonio, TXObesity Week® September 27-October 1, 2024, in Philadelphia, PA 2024 …See details»